HealthNotableSingle-source
5.3
Eli Lilly acquires AtaiBeckley for $2.8 billion to expand psychedelic drug portfolio
Brazil JournalLO·US · BR·1 day ago
HealthSingle-sourceLow
2.1
FDA approves Celcuity's first breast cancer drug
The FDA has granted approval to Celcuity for its first therapeutic product, a breast cancer treatment. This marks a significant corporate milestone for the biotech firm, though specific clinical efficacy data and market launch timelines remain to be detailed.
Score Breakdown
Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.2
Related signals
8 foundMarketsNotableSingle-sourceDeveloping
5.3
Kalshi expands prediction market offerings to include FDA regulatory outcomes and clinical trial results
Guardian WorldLO·US·1 day ago
HealthNotableSingle-sourceDeveloping
5.2
FDA CBER leadership transition aims to stabilize operations and review past regulatory decisions
STAT NewsLO·US·3 days ago
HealthNotableSingle-sourceDeveloping
5.2
Biogen mid-stage Alzheimer's drug trial shows cognitive decline reduction
STAT NewsLO·US·2 days ago
HealthSingle-sourceDeveloping
2.1
Hospital Posadas partners with Kuvia startup to integrate AI-driven cancer biomarker detection
La Nación (Argentina)LO·AR·2 days ago
HealthSingle-sourceDeveloping
2.1
Biotech startup enters obesity market targeting non-GLP-1 pathways
STAT NewsLO·US·3 days ago
MarketsSingle-source
2.1
Ascelia Pharma eliminates CFO position following FDA rejection
Dagens IndustriLO·SE · US·2 days ago
HealthNotableConfirmed
10.0
Argentina's ANMAT streamlines regulatory approval process for biological drugs
PerfilLO·AR·2 days ago